Munich Re’s €24 Dividend and €2.25bn Buyback Mask a Stock That Analysts Say Is 20% Undervalued

Munich Re shares fell 3.57% on ex-dividend day, but analysts see 20% upside as auditor switch, disciplined underwriting, and €5.3bn capital return support long-term value.

Munich Re’s shareholders got a bumper payout and a fresh capital return plan at the annual meeting, but the stock still took a 3.57% hit, closing at €524.20 on the day. The drop was textbook: the €24 per-share dividend, payable on 5 May 2026, triggered the ex-dividend effect. Yet beneath that surface-level selloff, a deeper story is unfolding — one of auditor upheaval, disciplined underwriting, and a stock that a chorus of analysts believes is trading well below fair value.

The dividend hike itself was a surprise. The market had pencilled in roughly €22 a share, but management delivered a 20% increase to €24, marking the 25th consecutive year without a cut. That payout is part of a broader €5.3bn capital return programme, which includes a new €2.25bn share buyback. The message from the board is clear: Munich Re has the balance-sheet firepower to reward investors even as it navigates a tougher pricing environment.

But the annual meeting wasn’t just about cash returns. After 139 gatherings, the company made a decisive break with its auditor. KPMG will take over from EY for the 2026 financial year, a move forced by the fallout from the Wirecard scandal. Germany’s audit watchdog APAS had slapped EY with a ban on taking new clients, and Munich Re drew the logical conclusion. KPMG is no stranger to the account — it audited the reinsurer until 2019 — and will also handle sustainability reporting, a growing requirement under Europe’s CSRD framework.

Operationally, the focus is on margin discipline, not volume. At the January 2026 renewal season, portfolio pricing slipped 2.5%, with natural catastrophe covers falling by around 6%. Munich Re walked away from business that didn’t meet its return thresholds, and the result was a 7.8% drop in gross written premiums to €13.7bn. A strong euro added headwinds, eating into premiums and profits that are largely denominated in US dollars. Management is betting that this selective approach will underpin a net profit target of €6.3bn for 2026 and a return on equity above 18%. The longer-term “Ambition 2030” strategy calls for annual earnings-per-share growth of more than 8% and a payout ratio above 80%.

Analysts are broadly backing the stock. JP Morgan has an “Overweight” rating and a €655 price target, while Berenberg sees fair value at €629 and Barclays at €606. The consensus target sits at €612.50, roughly 20% above the last XETRA close of €510.80. Even the most cautious voice, RBC Capital Markets, puts the stock at €560 — still above current levels. On a historical price-to-earnings basis using the past decade’s average, the fair value is around €600, implying a 15% discount today.

Technically, the €503 zone is acting as a support floor. If it holds, the stock could attempt to close the open downside gap toward €521.40. Resistance lies around the moving averages near €540. The next major catalyst comes on 12 May 2026, when Munich Re releases its first-quarter results. Investors will be watching for claims development data and confirmation that the full-year targets remain intact.

There are also changes in the boardroom. Clement B. Booth stepped down at the end of the annual meeting, and shareholders cleared the way for former CEO Joachim Wenning to join the supervisory board after the statutory cooling-off period. The new lineup will face its first real test when the Q1 numbers land — the initial checkpoint for whether the strategy of restraint can deliver the growth the market is pricing in.